Sinovac booster effective for primary vaccine recipients

by TMR / pic by TMR FILE

A STUDY conducted by Yale University, the Dominican Republic’s Ministry of Health and other institutions shows that two doses of Sinovac Covid-19 vaccine with a booster Pfizer-BioNTech dose are less effective and produce a lower immune response against the Omicron variant compared with other strains.

In a statement issued by Pharmaniaga yesterday, it said the research also demonstrated that the primary two-dose of Sinovac vaccine with the Pfizer dose produced an antibody response similar to a two-dose mRNA vaccine.

Meanwhile, in a separate recent research published by Sinovac Biotech Ltd shows that three doses of Sinovac Covid-19 vaccine produced higher neutralising antibodies in 95% of recipients compared with 3.3% by the second dose against variant of concern (VOC), including Omicron.

Its spokesperson Pearson Liu said that this research provides reassurance that inactivated vaccines, one of the most widely used vaccines globally, remains effective in the fight against Covid-19.

“As the world continues to combat the emergence of new COVID-19 variants, the results support a three-dose immunisation regimen to ensure greater protection against Covid-19, a finding which aligns with the advice of the World Health Organisation (WHO) and local health authorities around the world for all types of Covid-19 vaccines,” he said.

“Based on these findings, getting a Sinovac  booster is highly recommended for those who have completed their primary vaccination, which offers better protection by creating an antibody response and providing good protection, especially against severe disease,” Pharmaniaga said in the same statement.

Members of the public can obtain their Sinovac booster dose through walk in and appointments at our designated clinics across the country, with information available on its official website and Facebook account.